Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,683 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
3D radiotherapy can be safely combined with sandwich systemic gemcitabine chemotherapy in the management of pancreatic cancer: factors influencing outcome.
Spry N, Harvey J, Macleod C, Borg M, Ngan SY, Millar JL, Graham P, Zissiadis Y, Kneebone A, Carroll S, Davies T, Reece WH, Iacopetta B, Goldstein D. Spry N, et al. Among authors: davies t. Int J Radiat Oncol Biol Phys. 2008 Apr 1;70(5):1438-46. doi: 10.1016/j.ijrobp.2007.08.070. Epub 2007 Dec 31. Int J Radiat Oncol Biol Phys. 2008. PMID: 18164859 Clinical Trial.
Gemcitabine with a specific conformal 3D 5FU radiochemotherapy technique is safe and effective in the definitive management of locally advanced pancreatic cancer.
Goldstein D, Van Hazel G, Walpole E, Underhill C, Kotasek D, Michael M, Shapiro J, Davies T, Reece W, Harvey J, Spry N. Goldstein D, et al. Among authors: davies t. Br J Cancer. 2007 Aug 20;97(4):464-71. doi: 10.1038/sj.bjc.6603900. Epub 2007 Jul 24. Br J Cancer. 2007. PMID: 17653074 Free PMC article. Clinical Trial.
Phase II study of gemcitabine and oxaliplatin in patients with recurrent ovarian cancer: an Australian and New Zealand Gynaecological Oncology Group study.
Harnett P, Buck M, Beale P, Goldrick A, Allan S, Fitzharris B, De Souza P, Links M, Kalimi G, Davies T, Stuart-Harris R. Harnett P, et al. Among authors: davies t. Int J Gynecol Cancer. 2007 Mar-Apr;17(2):359-66. doi: 10.1111/j.1525-1438.2007.00763.x. Int J Gynecol Cancer. 2007. PMID: 17362313 Clinical Trial.
Core outcome set of daily monitoring of gastrointestinal function in adult critically ill patients: a modified Delphi consensus process (COSMOGI).
Bachmann KF, Jenkins B, Asrani V, Bear DE, Bolondi G, Boraso S, Casaer MP, Chang Z, Coopersmith CM, Cotoia A, Davies T, De Man A, Elke G, Gundogan K, Gunst J, Kvolik S, Laube M, Lindner M, Lopez-Delgado JC, Loudet C, Matsa R, Pardo E, Piva S, Puthucheary Z, Rice TW, Ruiz-Santana S, Schaller SJ, Starkopf J, Stoppe C, Van Zanten A, Reintam Blaser A. Bachmann KF, et al. Among authors: davies t. Crit Care. 2024 Dec 18;28(1):420. doi: 10.1186/s13054-024-05192-8. Crit Care. 2024. PMID: 39695807 Free PMC article.
A horizon scan of biological conservation issues for 2025.
Sutherland WJ, Brotherton PNM, Butterworth HM, Clarke SJ, Davies TE, Doar N, Esmail N, Fleishman E, Gaston KJ, Herbert-Read JE, Hughes AC, Hughes J, Kaartokallio H, Koh LP, Kumar R, Lickorish FA, Littler H, Palardy JE, Pearce-Higgins JW, Peck LS, Pettorelli N, Pretty J, Schloss IR, Spalding MD, Ten Brink D, Tew ER, Timoshyna A, Tubbs N, Watson JEM, Wentworth J, Wilson JD, Thornton A. Sutherland WJ, et al. Among authors: davies te. Trends Ecol Evol. 2025 Jan;40(1):80-89. doi: 10.1016/j.tree.2024.11.002. Epub 2024 Dec 4. Trends Ecol Evol. 2025. PMID: 39638664 Free article.
1,683 results